Total planned funding: $117,219,040
Allocations
Countries/Regions
| Ukraine | $117,219,040 |
Organizational Types
| Private Contractor | $28,990,981 |
| Unknown | $26,780,549 |
| NGO | $25,013,014 |
| Own Agency | $14,270,195 |
| Multi-lateral Agency | $10,775,607 |
| University | $5,277,000 |
| Other USG Agency | $3,061,694 |
| Implementing Agency | $2,800,000 |
| Host Country Government Agency | $250,000 |
Program Areas
| Governance and Systems | $50,671,559 |
| Treatment | $24,203,765 |
| Prevention | $12,590,795 |
| Testing | $11,104,112 |
| Management and Operations | $9,554,542 |
| Care | $8,681,567 |
Budget Codes
| OHSS: Health Systems Strengthening | $24,798,361 |
| HVSI: Strategic Information | $16,165,187 |
| HTXS: Treatment: Adult Treatment | $12,772,651 |
| HTXD: Treatment: ARV Drugs | $11,431,114 |
| HVCT: Testing: HIV Testing and Counseling | $11,104,112 |
| HLAB: Laboratory Infrastructure | $9,708,011 |
| HVMS: Management and Operations | $9,554,542 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,857,557 |
| HVTB: Care: TB/HIV | $5,417,388 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $5,229,387 |
| HBHC: Care: Adult Care and Support | $1,821,035 |
| HKID: Care: Orphans and Vulnerable Children | $1,443,144 |
| HMBL: Biomedical Prevention: Blood Safety | $1,133,557 |
| HMIN: Biomedical Prevention: Injection Safety | $250,000 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $120,294 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$27,485,265
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$13,157,195
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions